The classified management of Sichuan's three major medical insurance lists contains 18 dual-channel varieties

6667px;white-space:normal;'>

6667px;white-space:normal;'> 88 single-line payment for medicines: Five fixed management, the provincial medical insurance pays 75%

6667px;white-space:normal;'> The "five fixed" management is implemented for 88 single-line payment drugs (Annex 1) including vedrilizumab in the National Talks drug, namely: designated accreditation agency, designated treatment organization, designated responsible physician, designated drug supply organization, and real-name system management.

6667px;white-space:normal;'> Drug supply organization management: 88 single-line payment drugs implement dual-channel drug supply guarantee, that is, 29 treatment organizations and 40 designated retail pharmacies are jointly responsible for supply guarantees.

6667px;white-space:normal;'> Payment ratio and cumulative cap line: The payment ratio of the provincial-level single-bank drug basic medical insurance coordinating fund payment is 75%.

6667px;white-space:normal;'> Expense settlement: When the medical insurance participants at the provincial level and in different places in the province settle on the provincial-level drug supply institutions, the part of the medical insurance fund payment is settled by the drug supply institutions and the provincial medical insurance affairs center; the expenses borne by the insured persons are paid by the individual The individual settles with the drug supply institution.

6667px;white-space:normal;'> 136 included in Class B drugs: implemented in accordance with the current provincial medical insurance policy

6667px;white-space:normal;'> Include 136 drugs (Annex 2) including Vonolasan in the National Talks drug in the management of Class B drugs.

6667px;white-space:normal;'> Drug supply institutions: designated medical institutions are responsible for the supply of such drugs.

6667px;white-space:normal;'> Expense settlement: The personal burden of the insured person is settled by the individual and the designated medical institution, and the medical insurance payment is settled by the designated medical institution and the Provincial Medical Insurance Affairs Center.

6667px;white-space:normal;'> Cumulative capping line: The negotiated drugs that are included in the management of category B drugs are paid in accordance with the current relevant regulations of the provincial medical insurance, and are included in the capping line of the provincial-level insured persons this year.

6667px;white-space:normal;'> 18 high-value drugs: dual-channel drug supply guarantee, in principle, choose one drug corresponding to the same disease

6667px;white-space:normal;'> 18 high-value drugs such as recombinant human thrombopoietin (Annex 3) will be included in the management of Class B drugs after real-name registration and pre-review in treatment institutions.

6667px;white-space:normal;'> Drug supply institutions: High-value drugs are provided with dual-channel drug supply guarantee, and the drug supply institutions are paid separately.

6667px;white-space:normal;'> Expense settlement: When the medical insurance participants at the provincial level and in different places in the province settle on the provincial-level drug supply institutions, the part of the medical insurance fund payment is settled by the drug supply institutions and the provincial medical insurance affairs center; the expenses borne by the insured persons are paid by the individual The individual settles with the drug supply institution.

6667px;white-space:normal;'> Medication management: The treatment institution should do a good job of medication management, and in principle choose to use a corresponding drug for the same disease, unless there is a clear basis for clinical diagnosis and treatment guidelines, clinical pathways, and drug instructions issued or recommended by the state.

6667px;white-space:normal;'> Remote medical treatment management

6667px;white-space:normal;'> Provincial-level remote medical records personnel who use single-line payment for drugs and high-value drugs at the record place must provide relevant inspection and inspection materials for the type of disease and drug identification (pre-review), and the provincial-level certification (treatment) organization will conduct comprehensive evaluation and certification (Pre-review), the cash advance fee shall be paid in accordance with the relevant policies and regulations of the provincial level.

6667px;white-space:normal;'> If the registration place has opened the direct settlement business for special medicines in the province, the insured persons at the provincial level can also conduct a comprehensive assessment at the local accreditation (treatment) institution relying on the special medicines system in the province.

6667px;white-space:normal;'>